Condition
Benign Breast Neoplasm
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07465523Recruiting
A Novel Approach in the Evaluation of Breast Masses With Doppler US
NCT06090630Early Phase 1CompletedPrimary
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
NCT01849250Phase 2CompletedPrimary
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
NCT02172989CompletedPrimary
Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm.
Showing all 4 trials